ANTHONY TAPARO - 15 Mar 2022 Form 4 Insider Report for Surgery Partners, Inc. (SGRY)

Role
Chief Growth Officer
Signature
/s/ Jennifer Baldock, Attorney-in-Fact
Issuer symbol
SGRY
Transactions as of
15 Mar 2022
Net transactions value
-$452,496
Form type
4
Filing time
17 Mar 2022, 17:43:01 UTC
Previous filing
15 Mar 2022
Next filing
28 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGRY Common Stock Sale $366,102 -7,426 -6.6% $49.30 105,867 15 Mar 2022 Direct F1, F2
transaction SGRY Common Stock Sale $86,394 -1,698 -1.6% $50.88 104,169 16 Mar 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 13, 2022.
F2 The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 15, 2022.